Forte Biosciences Inc Sustainability Reports
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune and autoimmune-related indications.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900Z84WFDHPS3JP76
4 reports from 2020 to 2024
Company Profile
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune and autoimmune-related indications.
Reports
4 total
Limited sustainability disclosure available
The reports currently shown are annual reports without dedicated sustainability sections.
Years
